ID   1-LN
AC   CVCL_L211
SY   1LN; 1-LN-PC-3-1A; 1LN-PC31A
DR   BTO; BTO:0005352
DR   IARC_TP53; 2305
DR   Wikidata; Q54399843
RX   PubMed=4007233;
RX   PubMed=8510267;
CC   Sequence variation: Homozygous for TP53 p.Lys139fs*31 (c.413delC) (PubMed=8510267).
CC   Derived from metastatic site: Bone.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 25-02-19; Version: 9
//
RX   PubMed=4007233; DOI=10.1159/000163308;
RA   Ware J.L., Lieberman A.P., Webb K.S., Vollmer R.T.;
RT   "Factors influencing phenotypic diversity of human prostate carcinoma
RT   cells metastasizing in athymic nude mice.";
RL   Exp. Cell Biol. 53:163-169(1985).
//
RX   PubMed=8510267; DOI=10.1016/S0022-5347(17)35458-7;
RA   Effert P.J., McCoy R.H., Walther P.J., Liu E.T.;
RT   "p53 gene alterations in human prostate carcinoma.";
RL   J. Urol. 150:257-261(1993).
//